NOHO, Inc.
NOHO, Inc. DRNK Peers
See (DRNK) competitors and their performances in Stock Market.
Peer Comparison Table: Beverages - Non-Alcoholic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DRNK | $0.00 | +20.00% | 5.5M | N/A | N/A | N/A |
| NNFSF | $4.84 | N/A | 54.4B | 32.27 | $0.15 | +2.19% |
| CCHGY | $52.77 | -0.43% | 19.2B | 20.69 | $2.55 | +2.12% |
| CCHBF | $52.74 | +2.00% | 19.2B | 20.68 | $2.55 | +2.09% |
| EMBVF | $10.68 | -0.24% | 18.4B | 15.94 | $0.67 | +2.90% |
| ITONF | $61.41 | N/A | 13.5B | 87.73 | $0.70 | +0.30% |
| BTVCY | $29.51 | N/A | 7.3B | 23.99 | $1.23 | +2.75% |
| YKLTF | $20.32 | N/A | 6.1B | 19.35 | $1.05 | +1.11% |
| YKLTY | $9.99 | -0.99% | 6B | 19.21 | $0.52 | +0.75% |
| COCSF | $9.15 | -8.16% | 4.6B | 15.78 | $0.58 | +3.64% |
Stock Comparison
DRNK vs NNFSF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, NNFSF has a market cap of 54.4B. Regarding current trading prices, DRNK is priced at $0.00, while NNFSF trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas NNFSF's P/E ratio is 32.27. In terms of profitability, DRNK's ROE is -0.36%, compared to NNFSF's ROE of +0.43%. Regarding short-term risk, DRNK is more volatile compared to NNFSF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs CCHGY Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, CCHGY has a market cap of 19.2B. Regarding current trading prices, DRNK is priced at $0.00, while CCHGY trades at $52.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas CCHGY's P/E ratio is 20.69. In terms of profitability, DRNK's ROE is -0.36%, compared to CCHGY's ROE of +0.21%. Regarding short-term risk, DRNK is more volatile compared to CCHGY. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs CCHBF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, CCHBF has a market cap of 19.2B. Regarding current trading prices, DRNK is priced at $0.00, while CCHBF trades at $52.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas CCHBF's P/E ratio is 20.68. In terms of profitability, DRNK's ROE is -0.36%, compared to CCHBF's ROE of +0.21%. Regarding short-term risk, DRNK is more volatile compared to CCHBF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs EMBVF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, EMBVF has a market cap of 18.4B. Regarding current trading prices, DRNK is priced at $0.00, while EMBVF trades at $10.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas EMBVF's P/E ratio is 15.94. In terms of profitability, DRNK's ROE is -0.36%, compared to EMBVF's ROE of +0.15%. Regarding short-term risk, DRNK is more volatile compared to EMBVF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs ITONF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, ITONF has a market cap of 13.5B. Regarding current trading prices, DRNK is priced at $0.00, while ITONF trades at $61.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas ITONF's P/E ratio is 87.73. In terms of profitability, DRNK's ROE is -0.36%, compared to ITONF's ROE of +0.05%. Regarding short-term risk, DRNK is less volatile compared to ITONF. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs BTVCY Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, BTVCY has a market cap of 7.3B. Regarding current trading prices, DRNK is priced at $0.00, while BTVCY trades at $29.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas BTVCY's P/E ratio is 23.99. In terms of profitability, DRNK's ROE is -0.36%, compared to BTVCY's ROE of +0.34%. Regarding short-term risk, DRNK is more volatile compared to BTVCY. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs YKLTF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, YKLTF has a market cap of 6.1B. Regarding current trading prices, DRNK is priced at $0.00, while YKLTF trades at $20.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas YKLTF's P/E ratio is 19.35. In terms of profitability, DRNK's ROE is -0.36%, compared to YKLTF's ROE of +0.07%. Regarding short-term risk, DRNK is more volatile compared to YKLTF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs YKLTY Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, YKLTY has a market cap of 6B. Regarding current trading prices, DRNK is priced at $0.00, while YKLTY trades at $9.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas YKLTY's P/E ratio is 19.21. In terms of profitability, DRNK's ROE is -0.36%, compared to YKLTY's ROE of +0.07%. Regarding short-term risk, DRNK is more volatile compared to YKLTY. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs COCSF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, COCSF has a market cap of 4.6B. Regarding current trading prices, DRNK is priced at $0.00, while COCSF trades at $9.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas COCSF's P/E ratio is 15.78. In terms of profitability, DRNK's ROE is -0.36%, compared to COCSF's ROE of +0.17%. Regarding short-term risk, DRNK is more volatile compared to COCSF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs BTVCF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, BTVCF has a market cap of 4.1B. Regarding current trading prices, DRNK is priced at $0.00, while BTVCF trades at $16.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas BTVCF's P/E ratio is 26.89. In terms of profitability, DRNK's ROE is -0.36%, compared to BTVCF's ROE of +0.34%. Regarding short-term risk, DRNK is more volatile compared to BTVCF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs UNPSF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, UNPSF has a market cap of 3.8B. Regarding current trading prices, DRNK is priced at $0.00, while UNPSF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas UNPSF's P/E ratio is 14.77. In terms of profitability, DRNK's ROE is -0.36%, compared to UNPSF's ROE of +0.14%. Regarding short-term risk, DRNK is more volatile compared to UNPSF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs CCOJY Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, CCOJY has a market cap of 3B. Regarding current trading prices, DRNK is priced at $0.00, while CCOJY trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas CCOJY's P/E ratio is 121.18. In terms of profitability, DRNK's ROE is -0.36%, compared to CCOJY's ROE of -0.00%. Regarding short-term risk, DRNK is more volatile compared to CCOJY. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs YNAJF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, YNAJF has a market cap of 2.7B. Regarding current trading prices, DRNK is priced at $0.00, while YNAJF trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas YNAJF's P/E ratio is 26.56. In terms of profitability, DRNK's ROE is -0.36%, compared to YNAJF's ROE of +0.09%. Regarding short-term risk, DRNK is less volatile compared to YNAJF. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs CCOJF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, CCOJF has a market cap of 2.2B. Regarding current trading prices, DRNK is priced at $0.00, while CCOJF trades at $12.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas CCOJF's P/E ratio is 67.79. In terms of profitability, DRNK's ROE is -0.36%, compared to CCOJF's ROE of +0.02%. Regarding short-term risk, DRNK is more volatile compared to CCOJF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs ITOEF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, ITOEF has a market cap of 2.2B. Regarding current trading prices, DRNK is priced at $0.00, while ITOEF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas ITOEF's P/E ratio is 25.00. In terms of profitability, DRNK's ROE is -0.36%, compared to ITOEF's ROE of +0.05%. Regarding short-term risk, DRNK is more volatile compared to ITOEF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs AQPW Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, AQPW has a market cap of 2B. Regarding current trading prices, DRNK is priced at $0.00, while AQPW trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas AQPW's P/E ratio is -26.94. In terms of profitability, DRNK's ROE is -0.36%, compared to AQPW's ROE of -7.72%. Regarding short-term risk, DRNK is more volatile compared to AQPW. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs OSOPF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, OSOPF has a market cap of 1.5B. Regarding current trading prices, DRNK is priced at $0.00, while OSOPF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas OSOPF's P/E ratio is 31.57. In terms of profitability, DRNK's ROE is -0.36%, compared to OSOPF's ROE of +0.10%. Regarding short-term risk, DRNK is more volatile compared to OSOPF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs FQVTF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, FQVTF has a market cap of 1.4B. Regarding current trading prices, DRNK is priced at $0.00, while FQVTF trades at $11.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas FQVTF's P/E ratio is 41.77. In terms of profitability, DRNK's ROE is -0.36%, compared to FQVTF's ROE of +0.09%. Regarding short-term risk, DRNK is more volatile compared to FQVTF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs LSDAF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, LSDAF has a market cap of 1.1B. Regarding current trading prices, DRNK is priced at $0.00, while LSDAF trades at $160.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas LSDAF's P/E ratio is 13.04. In terms of profitability, DRNK's ROE is -0.36%, compared to LSDAF's ROE of +0.11%. Regarding short-term risk, DRNK is more volatile compared to LSDAF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs BAGFF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, BAGFF has a market cap of 734.2M. Regarding current trading prices, DRNK is priced at $0.00, while BAGFF trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas BAGFF's P/E ratio is 18.86. In terms of profitability, DRNK's ROE is -0.36%, compared to BAGFF's ROE of +0.12%. Regarding short-term risk, DRNK is more volatile compared to BAGFF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs NJMVF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, NJMVF has a market cap of 697.2M. Regarding current trading prices, DRNK is priced at $0.00, while NJMVF trades at $19.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas NJMVF's P/E ratio is 106.06. In terms of profitability, DRNK's ROE is -0.36%, compared to NJMVF's ROE of +0.24%. Regarding short-term risk, DRNK is more volatile compared to NJMVF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs HAATF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, HAATF has a market cap of 202M. Regarding current trading prices, DRNK is priced at $0.00, while HAATF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas HAATF's P/E ratio is 10.05. In terms of profitability, DRNK's ROE is -0.36%, compared to HAATF's ROE of +0.15%. Regarding short-term risk, DRNK is less volatile compared to HAATF. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs UPCHY Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, UPCHY has a market cap of 51.6M. Regarding current trading prices, DRNK is priced at $0.00, while UPCHY trades at $119.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas UPCHY's P/E ratio is 20.07. In terms of profitability, DRNK's ROE is -0.36%, compared to UPCHY's ROE of +0.14%. Regarding short-term risk, DRNK is more volatile compared to UPCHY. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs CHFHY Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, CHFHY has a market cap of 46.9M. Regarding current trading prices, DRNK is priced at $0.00, while CHFHY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas CHFHY's P/E ratio is 8.48. In terms of profitability, DRNK's ROE is -0.36%, compared to CHFHY's ROE of +0.13%. Regarding short-term risk, DRNK is more volatile compared to CHFHY. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs PDPG Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, PDPG has a market cap of 37.3M. Regarding current trading prices, DRNK is priced at $0.00, while PDPG trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas PDPG's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to PDPG's ROE of +0.32%. Regarding short-term risk, DRNK is less volatile compared to PDPG. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs JSDA Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, JSDA has a market cap of 23.8M. Regarding current trading prices, DRNK is priced at $0.00, while JSDA trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas JSDA's P/E ratio is -2.28. In terms of profitability, DRNK's ROE is -0.36%, compared to JSDA's ROE of -2.43%. Regarding short-term risk, DRNK is more volatile compared to JSDA. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs MOJO Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, MOJO has a market cap of 8.9M. Regarding current trading prices, DRNK is priced at $0.00, while MOJO trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas MOJO's P/E ratio is -16.33. In terms of profitability, DRNK's ROE is -0.36%, compared to MOJO's ROE of -1.62%. Regarding short-term risk, DRNK is more volatile compared to MOJO. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs KRTL Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, KRTL has a market cap of 8.6M. Regarding current trading prices, DRNK is priced at $0.00, while KRTL trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas KRTL's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to KRTL's ROE of +1.23%. Regarding short-term risk, DRNK is more volatile compared to KRTL. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs HFBG Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, HFBG has a market cap of 6.7M. Regarding current trading prices, DRNK is priced at $0.00, while HFBG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas HFBG's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to HFBG's ROE of N/A. Regarding short-term risk, DRNK is less volatile compared to HFBG. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs RVBR Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, RVBR has a market cap of 5.3M. Regarding current trading prices, DRNK is priced at $0.00, while RVBR trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas RVBR's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to RVBR's ROE of -0.17%. Regarding short-term risk, DRNK is more volatile compared to RVBR. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs APRU Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, APRU has a market cap of 4.7M. Regarding current trading prices, DRNK is priced at $0.00, while APRU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas APRU's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to APRU's ROE of +1.42%. Regarding short-term risk, DRNK is less volatile compared to APRU. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs HIRU Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, HIRU has a market cap of 3.5M. Regarding current trading prices, DRNK is priced at $0.00, while HIRU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas HIRU's P/E ratio is 0.22. In terms of profitability, DRNK's ROE is -0.36%, compared to HIRU's ROE of +0.12%. Regarding short-term risk, DRNK is more volatile compared to HIRU. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs FLWBF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, FLWBF has a market cap of 3.4M. Regarding current trading prices, DRNK is priced at $0.00, while FLWBF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas FLWBF's P/E ratio is -0.15. In terms of profitability, DRNK's ROE is -0.36%, compared to FLWBF's ROE of -0.92%. Regarding short-term risk, DRNK is more volatile compared to FLWBF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs NTEI Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, NTEI has a market cap of 2.7M. Regarding current trading prices, DRNK is priced at $0.00, while NTEI trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas NTEI's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to NTEI's ROE of -3.63%. Regarding short-term risk, DRNK is more volatile compared to NTEI. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs INKW Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, INKW has a market cap of 2.1M. Regarding current trading prices, DRNK is priced at $0.00, while INKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas INKW's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to INKW's ROE of -0.01%. Regarding short-term risk, DRNK is more volatile compared to INKW. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs PLVFF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, PLVFF has a market cap of 2.1M. Regarding current trading prices, DRNK is priced at $0.00, while PLVFF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas PLVFF's P/E ratio is -1.50. In terms of profitability, DRNK's ROE is -0.36%, compared to PLVFF's ROE of -4.78%. Regarding short-term risk, DRNK is more volatile compared to PLVFF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs PURT Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, PURT has a market cap of 1.7M. Regarding current trading prices, DRNK is priced at $0.00, while PURT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas PURT's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to PURT's ROE of +0.07%. Regarding short-term risk, DRNK is less volatile compared to PURT. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs RMHB Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, RMHB has a market cap of 1.6M. Regarding current trading prices, DRNK is priced at $0.00, while RMHB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas RMHB's P/E ratio is -0.13. In terms of profitability, DRNK's ROE is -0.36%, compared to RMHB's ROE of -1.00%. Regarding short-term risk, DRNK is more volatile compared to RMHB. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs FBEC Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, FBEC has a market cap of 1.2M. Regarding current trading prices, DRNK is priced at $0.00, while FBEC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas FBEC's P/E ratio is 0.01. In terms of profitability, DRNK's ROE is -0.36%, compared to FBEC's ROE of +0.00%. Regarding short-term risk, DRNK is more volatile compared to FBEC. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs ASII Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, ASII has a market cap of 663.4K. Regarding current trading prices, DRNK is priced at $0.00, while ASII trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas ASII's P/E ratio is -0.01. In terms of profitability, DRNK's ROE is -0.36%, compared to ASII's ROE of -0.60%. Regarding short-term risk, DRNK is less volatile compared to ASII. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs FMBV Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, FMBV has a market cap of 509.8K. Regarding current trading prices, DRNK is priced at $0.00, while FMBV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas FMBV's P/E ratio is -0.01. In terms of profitability, DRNK's ROE is -0.36%, compared to FMBV's ROE of +0.01%. Regarding short-term risk, DRNK is less volatile compared to FMBV. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs HSEEF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, HSEEF has a market cap of 410.4K. Regarding current trading prices, DRNK is priced at $0.00, while HSEEF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas HSEEF's P/E ratio is -0.40. In terms of profitability, DRNK's ROE is -0.36%, compared to HSEEF's ROE of -19.98%. Regarding short-term risk, DRNK is more volatile compared to HSEEF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs VGID Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, VGID has a market cap of 378.4K. Regarding current trading prices, DRNK is priced at $0.00, while VGID trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas VGID's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to VGID's ROE of +0.00%. Regarding short-term risk, DRNK is more volatile compared to VGID. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs KGKG Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, KGKG has a market cap of 245.3K. Regarding current trading prices, DRNK is priced at $0.00, while KGKG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas KGKG's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to KGKG's ROE of +0.29%. Regarding short-term risk, DRNK is less volatile compared to KGKG. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs FHBC Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, FHBC has a market cap of 199.6K. Regarding current trading prices, DRNK is priced at $0.00, while FHBC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas FHBC's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to FHBC's ROE of +0.00%. Regarding short-term risk, DRNK is more volatile compared to FHBC. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs EQLB Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, EQLB has a market cap of 185.6K. Regarding current trading prices, DRNK is priced at $0.00, while EQLB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas EQLB's P/E ratio is -0.43. In terms of profitability, DRNK's ROE is -0.36%, compared to EQLB's ROE of +0.16%. Regarding short-term risk, DRNK is less volatile compared to EQLB. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs DNAX Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, DNAX has a market cap of 171.8K. Regarding current trading prices, DRNK is priced at $0.00, while DNAX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas DNAX's P/E ratio is 0.01. In terms of profitability, DRNK's ROE is -0.36%, compared to DNAX's ROE of +0.13%. Regarding short-term risk, DRNK is more volatile compared to DNAX. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs GHMP Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, GHMP has a market cap of 155.5K. Regarding current trading prices, DRNK is priced at $0.00, while GHMP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas GHMP's P/E ratio is -0.00. In terms of profitability, DRNK's ROE is -0.36%, compared to GHMP's ROE of -0.54%. Regarding short-term risk, DRNK is more volatile compared to GHMP. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs MLHC Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, MLHC has a market cap of 120K. Regarding current trading prices, DRNK is priced at $0.00, while MLHC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas MLHC's P/E ratio is -0.01. In terms of profitability, DRNK's ROE is -0.36%, compared to MLHC's ROE of +0.00%. Regarding short-term risk, DRNK is less volatile compared to MLHC. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs DNDT Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, DNDT has a market cap of 119.7K. Regarding current trading prices, DRNK is priced at $0.00, while DNDT trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas DNDT's P/E ratio is -0.01. In terms of profitability, DRNK's ROE is -0.36%, compared to DNDT's ROE of +0.03%. Regarding short-term risk, DRNK is more volatile compared to DNDT. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs NBVG Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, NBVG has a market cap of 25.6K. Regarding current trading prices, DRNK is priced at $0.00, while NBVG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas NBVG's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to NBVG's ROE of -3.18%. Regarding short-term risk, DRNK is less volatile compared to NBVG. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs STZU Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, STZU has a market cap of 22.9K. Regarding current trading prices, DRNK is priced at $0.00, while STZU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas STZU's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to STZU's ROE of N/A. Regarding short-term risk, DRNK is less volatile compared to STZU. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs KRED Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, KRED has a market cap of 22.6K. Regarding current trading prices, DRNK is priced at $0.00, while KRED trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas KRED's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to KRED's ROE of +0.00%. Regarding short-term risk, DRNK is more volatile compared to KRED. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs PPBV Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, PPBV has a market cap of 22.5K. Regarding current trading prices, DRNK is priced at $0.00, while PPBV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas PPBV's P/E ratio is -0.02. In terms of profitability, DRNK's ROE is -0.36%, compared to PPBV's ROE of -2.55%. Regarding short-term risk, DRNK is less volatile compared to PPBV. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs FGFT Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, FGFT has a market cap of 22.4K. Regarding current trading prices, DRNK is priced at $0.00, while FGFT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas FGFT's P/E ratio is -0.00. In terms of profitability, DRNK's ROE is -0.36%, compared to FGFT's ROE of N/A. Regarding short-term risk, DRNK is more volatile compared to FGFT. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs BGEM Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, BGEM has a market cap of 15.4K. Regarding current trading prices, DRNK is priced at $0.00, while BGEM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas BGEM's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to BGEM's ROE of -3.20%. Regarding short-term risk, DRNK is less volatile compared to BGEM. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs BVNNF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, BVNNF has a market cap of 12.3K. Regarding current trading prices, DRNK is priced at $0.00, while BVNNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas BVNNF's P/E ratio is -0.00. In terms of profitability, DRNK's ROE is -0.36%, compared to BVNNF's ROE of +6.21%. Regarding short-term risk, DRNK is more volatile compared to BVNNF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs ALKM Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, ALKM has a market cap of 8.6K. Regarding current trading prices, DRNK is priced at $0.00, while ALKM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas ALKM's P/E ratio is -0.01. In terms of profitability, DRNK's ROE is -0.36%, compared to ALKM's ROE of -0.17%. Regarding short-term risk, DRNK is more volatile compared to ALKM. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs TBEV Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, TBEV has a market cap of 4K. Regarding current trading prices, DRNK is priced at $0.00, while TBEV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas TBEV's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to TBEV's ROE of +1.28%. Regarding short-term risk, DRNK is more volatile compared to TBEV. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs SWRI Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, SWRI has a market cap of 1.9K. Regarding current trading prices, DRNK is priced at $0.00, while SWRI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas SWRI's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to SWRI's ROE of +0.50%. Regarding short-term risk, DRNK is more volatile compared to SWRI. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs HKBV Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, HKBV has a market cap of 1.1K. Regarding current trading prices, DRNK is priced at $0.00, while HKBV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas HKBV's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to HKBV's ROE of +0.71%. Regarding short-term risk, DRNK is less volatile compared to HKBV. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs MCHA Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, MCHA has a market cap of 505. Regarding current trading prices, DRNK is priced at $0.00, while MCHA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas MCHA's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to MCHA's ROE of -0.54%. Regarding short-term risk, DRNK is more volatile compared to MCHA. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs BBDA Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, BBDA has a market cap of 287. Regarding current trading prices, DRNK is priced at $0.00, while BBDA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas BBDA's P/E ratio is 0.01. In terms of profitability, DRNK's ROE is -0.36%, compared to BBDA's ROE of +0.33%. Regarding short-term risk, DRNK is more volatile compared to BBDA. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs AQUI Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, AQUI has a market cap of 20. Regarding current trading prices, DRNK is priced at $0.00, while AQUI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas AQUI's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to AQUI's ROE of +0.03%. Regarding short-term risk, DRNK is less volatile compared to AQUI. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs ABVG Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, ABVG has a market cap of 3. Regarding current trading prices, DRNK is priced at $0.00, while ABVG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas ABVG's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to ABVG's ROE of +0.00%. Regarding short-term risk, DRNK is more volatile compared to ABVG. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs GGGRF Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, GGGRF has a market cap of 0. Regarding current trading prices, DRNK is priced at $0.00, while GGGRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas GGGRF's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to GGGRF's ROE of N/A. Regarding short-term risk, DRNK is more volatile compared to GGGRF. This indicates potentially higher risk in terms of short-term price fluctuations for DRNK.
DRNK vs CLCL Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, CLCL has a market cap of 0. Regarding current trading prices, DRNK is priced at $0.00, while CLCL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas CLCL's P/E ratio is N/A. In terms of profitability, DRNK's ROE is -0.36%, compared to CLCL's ROE of N/A. Regarding short-term risk, DRNK is less volatile compared to CLCL. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.
DRNK vs RMIL Comparison
DRNK plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRNK stands at 5.5M. In comparison, RMIL has a market cap of 0. Regarding current trading prices, DRNK is priced at $0.00, while RMIL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRNK currently has a P/E ratio of N/A, whereas RMIL's P/E ratio is 0.00. In terms of profitability, DRNK's ROE is -0.36%, compared to RMIL's ROE of N/A. Regarding short-term risk, DRNK is less volatile compared to RMIL. This indicates potentially lower risk in terms of short-term price fluctuations for DRNK.